Genome informatics specialist played
central role in business development activities resulting in award
of more than $40M in federal contracts with bioinformatics and
-omics focus
CHAPEL HILL, NC, UNITED STATES - Jul 16, 2014 - David
Hall Joins Rho as Principal Investigator of
Bioinformatics
Genome informatics specialist played central role in
business development activities resulting in award of more than
$40M in federal contracts with bioinformatics and -omics
focus
Chapel Hill, NC ̶ DATE Rho, a
contract research organization (CRO) focused on bringing new
products to market through a full range of product development
services, today announced that David Hall has joined its team as a
principal investigator (PI) specializing in bioinformatics at its
Research Triangle Park headquarters in North Carolina. David brings
more than 12 years of experience in bioinformatics as a principal
investigator, general manager, project manager, bioinformatics
lead, programmer/analyst, data modeler and software engineer.
As a principal investigator at Rho, David will serve as the
group leader for bioinformatics in the consolidated Division of
Allergy, Immunology and Transplantation (DAIT) application of the
National Institute of Allergy and Infectious Diseases (NIAID) and
of the National Institutes of Health (NIH) proposal.
David joins Rho most recently from Syngenta where he specialized
in genome informatics, overseeing the development of genomic data
systems and tools supporting trait gene discovery and molecular
breeding. Additionally, he served as the principal investigator on
two National Institutes of Health (NIH)-funded contracts focusing
on bioinformatics and data coordination while at RTI
International. As one of the initial hires into the RTI
International Bioinformatics Program, David played a central role
in business development activities resulting in the award of more
than $40M in federal contracts and grants with a bioinformatics or
-omics focus.
Davids distinguished bioinformatics background combined with
his leadership in genome informatics at a world-class biotechnology
company make him a perfect fit for this opportunity, said Russ
Helms, Ph.D., chief executive officer for Rho. We look
forward to Davids contribution as the group leader of
bioinformatics and to utilizing his expertise to enhance the
scientific reputation of Rho and its 30-year track record of
leading federally and commercially funded research, said Dr.
Helms.
To learn more about Rho, please visit http://www.rhoworld.com/rho/career-center.
About Rho
Rho, a privately-held, contract research organization (CRO)
located in Chapel Hill, NC, provides a full range of clinical
research services across the entire drug development process. For
30 years, Rho has been a trusted partner to some of the industrys
leading pharmaceutical, biotechnology, and medical device companies
as well as academic and government organizations. Our commitment to
excellence, our innovative technologies, and our therapeutic
expertise accelerate time to market, maximize returns on
investment, and lead to an exceptional customer experience. Please
follow us on Twitter.
###